Correlation Between Beijing Wantai and Chengdu Spaceon

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beijing Wantai and Chengdu Spaceon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beijing Wantai and Chengdu Spaceon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beijing Wantai Biological and Chengdu Spaceon Electronics, you can compare the effects of market volatilities on Beijing Wantai and Chengdu Spaceon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beijing Wantai with a short position of Chengdu Spaceon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beijing Wantai and Chengdu Spaceon.

Diversification Opportunities for Beijing Wantai and Chengdu Spaceon

0.28
  Correlation Coefficient

Modest diversification

The 3 months correlation between Beijing and Chengdu is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Beijing Wantai Biological and Chengdu Spaceon Electronics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chengdu Spaceon Elec and Beijing Wantai is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beijing Wantai Biological are associated (or correlated) with Chengdu Spaceon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chengdu Spaceon Elec has no effect on the direction of Beijing Wantai i.e., Beijing Wantai and Chengdu Spaceon go up and down completely randomly.

Pair Corralation between Beijing Wantai and Chengdu Spaceon

Assuming the 90 days trading horizon Beijing Wantai Biological is expected to under-perform the Chengdu Spaceon. But the stock apears to be less risky and, when comparing its historical volatility, Beijing Wantai Biological is 1.52 times less risky than Chengdu Spaceon. The stock trades about -0.16 of its potential returns per unit of risk. The Chengdu Spaceon Electronics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  1,647  in Chengdu Spaceon Electronics on October 5, 2024 and sell it today you would lose (91.00) from holding Chengdu Spaceon Electronics or give up 5.53% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Beijing Wantai Biological  vs.  Chengdu Spaceon Electronics

 Performance 
       Timeline  
Beijing Wantai Biological 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Beijing Wantai Biological has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Chengdu Spaceon Elec 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chengdu Spaceon Electronics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Chengdu Spaceon is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Beijing Wantai and Chengdu Spaceon Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beijing Wantai and Chengdu Spaceon

The main advantage of trading using opposite Beijing Wantai and Chengdu Spaceon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beijing Wantai position performs unexpectedly, Chengdu Spaceon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chengdu Spaceon will offset losses from the drop in Chengdu Spaceon's long position.
The idea behind Beijing Wantai Biological and Chengdu Spaceon Electronics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets